Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1 Meningioma 1 Ependymoma 1

Interventions

Temozolomide 44 Magnetic Resonance Spectroscopy 40 Specimen Handling 29 Radiotherapy 19 Radiation 16 Bevacizumab 14 Biopsy 13 Radiosurgery 12 Nivolumab 12 X-Rays 10 Cyclophosphamide 9 Carboplatin 9 Nuclear Medicine Department, Hospital 7 Lomustine 7 Irinotecan 7 pembrolizumab 6 Ipilimumab 6 Cisplatin 6 AZD 6244 6 Vincristine 5 Topotecan 5 Phantoms, Imaging 5 Etoposide 5 CTLA-4 Antigen 5 ulixertinib 4 trametinib 4 olaparib 4 erdafitinib 4 dinutuximab 4 binimetinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

brigatinib × CNS × 30 days × Clear all

NCT04374305 2026-05-06

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡